ctrl K

Watchlist Price Alert

Silexion Therapeutics LTD (SLXN)

NASDAQ: SLXN · Real-Time Price · USD

0.99

-0.01 (-1.00%)

At close: May 02, 2025, 3:59 PM

1.00

0.81%

After-hours: May 02, 2025, 05:50 PM EDT

Silexion Therapeutics LTD Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a
Operating Income	n/a	-4.68M	-3.86M	-943.93K	-195.86K
Interest Income	n/a	153K	114K	6.37K	n/a
Pretax Income	16.51M	-5.08M	-3.46M	-755.22K	-195.86K
Net Income	16.51M	-4.94M	-3.21M	-755.22K	-195.86K
Selling & General & Admin	6.76M	928K	577K	943.93K	195.86K
Research & Development	5.82M	3.71M	3.23M	n/a	n/a
Other Expenses	n/a	45K	57K	n/a	n/a
Operating Expenses	12.57M	4.68M	3.86M	943.93K	195.86K
Interest Expense	n/a	9K	85K	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	4.68M	3.86M	-943.93K	-195.86K
Income Tax Expense	n/a	32K	24K	n/a	n/a
Shares Outstanding (Basic)	623.85K	8.15M	8.15M	1.65M	1.65M
Shares Outstanding (Diluted)	623.85K	8.15M	8.15M	1.65M	1.65M
EPS (Basic)	2.03	-0.61	-0.39	-0.46	-0.12
EPS (Diluted)	2.03	-0.61	-0.39	-0.46	-0.12
EBITDA	-16.43M	-4.64M	-3.8M	-755.22K	-195.86K
EBIT	n/a	-4.68M	-3.86M	-755.22K	-195.86K
Depreciation & Amortization	n/a	45K	57K	n/a	n/a